apalutamide
apalutamide is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: tablet, film coated.
Drug Details
- Generic Name
- apalutamide
- Brand Names
- N/A
- Application Number
- Sponsor
- Janssen Ortho LLC
- NDC Codes
- 1
- Dosage Forms
- TABLET, FILM COATED
- Routes
- N/A
- Active Ingredients
- APALUTAMIDE
Indications and Usage
1 INDICATIONS AND USAGE ERLEADA is indicated for the treatment of patients with Metastatic castration-sensitive prostate cancer (mCSPC) Non-metastatic castration-resistant prostate cancer (nmCRPC) ERLEADA is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive prostate cancer. ( 1 ) non-metastatic castration-resistant prostate cancer. ( 1 )